In triple negative breast cancer, the downregulation of the β-1,3-N-acetylglucosaminyl transferase (B3GNT3) enhances T cell mediated anti-tumour immunity mediated by PD-L1 and PD1 interaction [50]. This evidence concerns the gene CD274 and neoplasm.